Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for C4X Discovery

    Client Virtual Booth

    C4X DISCOVERY

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    C4X Discovery
    unitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    Manchester One 53 Portland Street Manchester M1 3LD
    Telephone
    Telephone
    +44 (0)161 235 5085
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.c4xdiscovery.com/
    Linkedin
    Linkedin
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    C4X Discovery Holdings Announces Divestment of Orexin-1 to Indivior for £15.95m
    C4X Discovery Holdings Announces Divestment of Orexin-1 to Indivior for £15.95m

    https://www.accesswire.com/viewarticle.aspx?id=771387&lang=en

    ACCESSWIRE
    01 Aug 2023
    Share Share
    C4X sells substance disorder drug rights to Indivior for $20M
    C4X sells substance disorder drug rights to Indivior for $20M

    https://www.fiercebiotech.com/biotech/c4x-sells-full-rights-substance-disorder-drug-indivior-part-inflammation-refocus

    James Waldron FIERCE BIOTECH
    01 Aug 2023
    Share Share
    C4XD and Garvan Institute of Research report patient stratification approach
    C4XD and Garvan Institute of Research report patient stratification approach

    https://www.globenewswire.com/news-release/2023/02/22/2612849/0/en/C4XD-and-Garvan-Institute-of-Medical-Research-report-successful-patient-stratification-approach-using-C4XD-s-new-precision-medicine-platform-PatientSeek.html

    GLOBENEWSWIRE
    22 Feb 2023
    Share Share
    C4XD and AstraZeneca enter $402m deal to develop respiratory disease therapy
    C4XD and AstraZeneca enter $402m deal to develop respiratory disease therapy

    https://www.pharmaceutical-technology.com/news/c4xd-astrazeneca-deal-respiratory-disease/

    PHARMACEUTICAL-TECHNOLOGY
    29 Nov 2022
    Share Share
    C4X Discovery Receives Sanofi Milestone Payment
    C4X Discovery Receives Sanofi Milestone Payment

    https://www.biospace.com/article/releases/c4x-discovery-receives-sanofi-milestone-payment/

    BIOSPACE
    06 Jul 2022
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search